Literature DB >> 12902625

A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease.

P Ragonese1, G Salemi, L Morgante, P Aridon, A Epifanio, D Buffa, F Scoppa, G Savettieri.   

Abstract

OBJECTIVE: To investigate the association between cigarette smoking, alcohol drinking, coffee consumption and Parkinson's disease (PD).
METHODS: We selected subjects affected by idiopathic PD, with a Mini-Mental State Examination of > or =24, and controls matched 1 to 1 with cases by age (+/- 2 years) and sex. Controls were randomly selected from the resident list of the same municipality of residence of the cases. We assessed cigarette smoking, alcohol drinking, and coffee consumption preceding the onset of PD or the corresponding time for controls using a structured questionnaire, which also evaluated the duration and dose of exposure. Using conditional logistic regression analysis, we calculated adjusted OR and 95% CI.
RESULTS: We interviewed 150 PD patients and 150 matched controls. Cigarette smoking (ever vs. never smokers OR = 0.66, 95% CI = 0.41-1.05, p = 0.08) did not show a statistically significant association with PD. We observed an inverse association between alcohol drinking (ever vs. never OR = 0.61, 95% CI = 0.39-0.97, p = 0.037) and coffee consumption (ever vs. never OR = 0.16, 95% CI 0.05-0.46, p = 0.0001) and PD. These associations remained significant after adjustment for other covariates: OR for ever vs. never alcohol consumption was 0.62 (95% CI = 0.43-0.89, p = 0.009) and that for coffee drinking 0.19 (95% CI = 0.07-0.52, p = 0.001). Heavy coffee consumption confirmed the inverse association between coffee and PD (more than 81 cup/year vs. none: OR = 0.20, 95% CI = 0.08-0.47, p < or = 0.0001).
CONCLUSIONS: Consistent with previous studies, our results suggest an inverse association between coffee drinking, alcohol consumption and PD. The multiple inverse association observed may indicate a complex interaction between genetic and environmental factors. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902625     DOI: 10.1159/000071193

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  19 in total

1.  Influence of coffee drinking and cigarette smoking on the risk of primary late onset blepharospasm: evidence from a multicentre case control study.

Authors:  G Defazio; D Martino; G Abbruzzese; P Girlanda; M Tinazzi; G Fabbrini; C Colosimo; M S Aniello; L Avanzino; M Buccafusca; G Majorana; C Trompetto; P Livrea; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-19       Impact factor: 10.154

2.  Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.

Authors:  N Hosseini Tabatabaei; B Babakhani; A Hosseini Tabatabaei; Z Vahabi; A Soltanzadeh
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 3.  Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.

Authors:  Blanca A Silva; Leonid Breydo; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

Review 4.  Coffee, Genetic Variants, and Parkinson's Disease: Gene-Environment Interactions.

Authors:  Naomi Yamada-Fowler; Peter Söderkvist
Journal:  J Caffeine Res       Date:  2015-03-01

Review 5.  Pathophysiological roles for purines: adenosine, caffeine and urate.

Authors:  Micaela Morelli; Anna R Carta; Anil Kachroo; Michael A Schwarzschild
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

6.  Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan.

Authors:  Wakaba Fukushima; Yoshihiro Miyake; Keiko Tanaka; Satoshi Sasaki; Chikako Kiyohara; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  BMC Neurol       Date:  2010-11-05       Impact factor: 2.474

7.  Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

Authors:  Thilo van Eimeren; Bénédicte Ballanger; Giovanna Pellecchia; Janis M Miyasaki; Anthony E Lang; Antonio P Strafella
Journal:  Neuropsychopharmacology       Date:  2009-09-09       Impact factor: 7.853

8.  Sensitivity and bias in decision-making under risk: evaluating the perception of reward, its probability and value.

Authors:  Madeleine E Sharp; Jayalakshmi Viswanathan; Linda J Lanyon; Jason J S Barton
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

9.  Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Juan Suárez; Eduardo Tolosa; Dolores Vilas; Iban Aldecoa; Joan Berenguer; Fátima Damas-Hermoso
Journal:  Antioxidants (Basel)       Date:  2021-05-01

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.